Literature DB >> 11451958

Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide.

K Lugardon1, S Chasserot-Golaz, A E Kieffer, R Maget-Dana, G Nullans, B Kieffer, D Aunis, M H Metz-Boutigue.   

Abstract

Vasostatin-I, the natural fragment of chromogranin A-(1-76), is a neuropeptide able to kill a large variety of fungi and yeast cells in the micromolar range. We have examined the antifungal properties of synthetic vasostatin-I-related peptides. The most active shortest peptide, named chromofungin, corresponds to the sequence Arg(47)-Leu(66). Extensive (1)H NMR analysis revealed that it adopts a helical structure. The biophysical mechanism implicated in the interaction of chromofungin with fungi and yeast cells was studied, showing the penetration of this peptide with different lipid monolayers. In order to examine thoroughly the antifungal activity of chromofungin, confocal laser microscopy was used to demonstrate the ability of the rhodamine-labeled peptide to interact with the fungal cell wall, to cross the plasma membrane, and to accumulate in Aspergillus fumigatus, Alternaria brassicola, and Candida albicans. Our present data reveal that chromofungin inhibits calcineurin activity, extending a previous observation that the N-terminal region of chromogranin A interacts with calmodulin in the presence of calcium. Therefore, the destabilization of fungal wall and plasma membrane, together with the possible intracellular inhibition of calmodulin-dependent enzymes, is likely to represent the mechanism by which vasostatin-I and chromofungin exert antifungal activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451958     DOI: 10.1074/jbc.M104670200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.

Authors:  William J Steinbach; Nina Singh; Jackie L Miller; Daniel K Benjamin; Wiley A Schell; Joseph Heitman; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Role of vasostatin-1 C-terminal region in fibroblast cell adhesion.

Authors:  Eleonora Dondossola; Anna Gasparri; Angela Bachi; Renato Longhi; Marie-Hélène Metz-Boutigue; Bruno Tota; Karen B Helle; Flavio Curnis; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

Review 3.  Chromogranins: from discovery to current times.

Authors:  Karen B Helle; Marie-Helene Metz-Boutigue; Maria Carmela Cerra; Tommaso Angelone
Journal:  Pflugers Arch       Date:  2017-09-05       Impact factor: 3.657

4.  Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice.

Authors:  Flavio Curnis; Anna Maria Gasparri; Renato Longhi; Barbara Colombo; Silvia D'Alessio; Fabio Pastorino; Mirco Ponzoni; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

Review 5.  Chromogranin A and the tumor microenvironment.

Authors:  Angelo Corti
Journal:  Cell Mol Neurobiol       Date:  2010-11-16       Impact factor: 5.046

6.  Plasma and tissue chromogranin in patients with adrenocortical adenomas.

Authors:  G P Bernini; A Moretti; M Borgioli; M Bardini; P Miccoli; P Berti; F Basolo; P Faviana; R Birindelli; A Salvetti
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

7.  Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei.

Authors:  Ruifang Li; Lin Zhang; Huiru Zhang; Yanjie Yi; Le Wang; Liang Chen; Lan Zhang
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

8.  Killing of Candida albicans by human salivary histatin 5 is modulated, but not determined, by the potassium channel TOK1.

Authors:  Didi Baev; Alberto Rivetta; Xuewei S Li; Slavena Vylkova; Esther Bashi; Clifford L Slayman; Mira Edgerton
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Antiproliferative effect and characterization of a novel antifungal peptide derived from human Chromogranin A.

Authors:  Rui-Fang Li; Ya-Li Lu; Yan-Bo Lu; Hui-Ru Zhang; Liang Huang; Yanli Yin; Lin Zhang; Shuai Liu; Zhifang Lu; Yanan Sun
Journal:  Exp Ther Med       Date:  2015-10-30       Impact factor: 2.447

10.  Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Authors:  Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Journal:  Cell Mol Life Sci       Date:  2009-12-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.